Emerging/evolving rationale and role for indication-based prescribing: going beyond adding indication simply to inform patient and pharmacist1
Domain | Emerging function | Example |
Decision support for drugs of choice | Help prescribers recall and access best/current Rx for diagnosis. | Enter: rheumatoid arthritis—CPOE suggests appropriate next drug to order. |
Facilitating antimicrobial stewardship. | Enter: cellulitis—CPOE lists the narrowest spectrum antibiotic choice based on local resistance rates and current recommendation. | |
Safer prescribing | Second piece of information to cross-check for wrong drug, patient and dose. | Erroneous orders of hydroxyzine 25 mg for hypertension, hydralazine 25 mg for itching would be easily recognised. |
Forcing function to filter CPOE choices to avoid look-alike sound-alike or computer menu ‘pull down’ errors. | Erroneous ordering of penicillamine instead of penicillin (next to each other on pull-down lists) is not possible since it does not appear as a choice for dental infection. | |
Patient education and adherence | Permit pharmacists and nurses to more meaningfully counsel patients on their medications. | Explain to patients why (and how) they need to take their prednisone or warfarin (so don’t have to guess among scores of indications). |
Help patients understand what each medication is for and avoid confusion leading to erroneously mixing up meds. | Patients stopping their drug for diabetes thinking it was the med for their depression, which had resolved. | |
Medication reconciliation and deprescribing | Group meds together to visually facilitate spotting duplicates or candidates to stop (or start). | Group/visualise all of patient’s blood pressure meds to assess current regimen for that problem, aiding in deciding on any needed changes. |
Reluctance to stop meds started by another clinician if uncertain why it was started. | Why is the patient taking a chronic PPI or digoxin? Depends on the indication whether it can be safely stopped (or tapered). | |
Prior authorisation (PA) | Prescriptions meeting indication-based criteria could have orders automatically approved without added ‘PA’ paperwork. | ‘Headaches refractory (or allergic) to 1st line medications’ (this is the indication) automatically approved for second-line more expensive agents. |
Artificial intelligence machine learning | Expanding role of mining of big databases for real-world drug discovery and research. Indications needed to evaluate drug’s effectiveness (and adverse effects) for that problem. | Exploring subsets of patients who most favourably respond or are more likely to experience an adverse effect. Outcome research of long-term effectiveness for a particular indication. |
CPOE, computer provider order entry; PPI, proton pump inhibitor.